What you are referring to has less to do with Medbox disclosures and more to do with OTC Markets not diseminating and displaying the information correctly. It is clearly addressed in the company's information statement. Keep in mind that the company is a Pink Sheet stock and as such a voluntary filer and has ZERO obligation to report the nuances you are taking issue with. Now that the company will be filing its Form 10 and fully reporting to the SEC, they can shed the stigma of being dubbed a pinksheet.